Wall Street brokerages expect that LifePoint Health, Inc. (NASDAQ:LPNT) will announce $1.60 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for LifePoint Health’s earnings, with the highest sales estimate coming in at $1.61 billion and the lowest estimate coming in at $1.58 billion. LifePoint Health posted sales of $1.59 billion in the same quarter last year, which suggests a positive year over year growth rate of 0.6%. The firm is scheduled to announce its next earnings report on Friday, October 27th.

On average, analysts expect that LifePoint Health will report full year sales of $1.60 billion for the current financial year, with estimates ranging from $6.44 billion to $6.49 billion. For the next fiscal year, analysts expect that the firm will report sales of $6.61 billion per share, with estimates ranging from $6.48 billion to $6.72 billion. Zacks’ sales averages are an average based on a survey of analysts that that provide coverage for LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $0.69 EPS. The company’s revenue for the quarter was up .2% on a year-over-year basis.

LPNT has been the subject of several recent analyst reports. BidaskClub upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Zacks Investment Research upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Monday, August 21st. TheStreet cut shares of LifePoint Health from a “b-” rating to a “c+” rating in a report on Wednesday, August 16th. Morgan Stanley initiated coverage on shares of LifePoint Health in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 target price for the company. Finally, Barclays PLC raised their target price on shares of LifePoint Health from $58.00 to $60.00 and gave the stock an “equal weight” rating in a report on Monday, May 1st. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $66.18.

WARNING: “Zacks: Brokerages Anticipate LifePoint Health, Inc. (LPNT) Will Announce Quarterly Sales of $1.60 Billion” was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://theolympiareport.com/2017/08/28/zacks-brokerages-anticipate-lifepoint-health-inc-lpnt-will-announce-quarterly-sales-of-1-60-billion.html.

In related news, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the sale, the chairman now directly owns 504,535 shares in the company, valued at $32,365,920.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares during the last quarter. LS Investment Advisors LLC raised its position in shares of LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after buying an additional 543 shares during the last quarter. US Bancorp DE raised its position in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after buying an additional 30 shares during the last quarter. Bank of Montreal Can raised its position in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock valued at $128,000 after buying an additional 306 shares during the last quarter. Finally, Shelton Capital Management acquired a new position in shares of LifePoint Health during the second quarter valued at $205,000. 99.59% of the stock is currently owned by hedge funds and other institutional investors.

LifePoint Health (NASDAQ:LPNT) opened at 56.85 on Monday. The company’s 50 day moving average is $60.77 and its 200 day moving average is $62.61. LifePoint Health has a 52-week low of $50.60 and a 52-week high of $70.95. The firm has a market cap of $2.28 billion, a P/E ratio of 12.73 and a beta of 0.86.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.